331 – 340 of 743
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Genetic control of the variable innate immune response to asymptomatic bacteriuria.
(
- Contribution to journal › Article
-
Mark
Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Complement deficiency states and associated infections.
(
- Contribution to journal › Article
-
Mark
The anti-angiogenic peptide anginex greatly enhances Galectin-1 binding affinity for glycoproteins
(
- Contribution to journal › Article
-
Mark
Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy.
(
- Contribution to journal › Article
-
Mark
Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).
(
- Contribution to journal › Article
-
Mark
Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.
(
- Contribution to journal › Article
- 2010
-
Mark
Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases
(
- Contribution to journal › Article
-
Mark
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
(
- Contribution to journal › Article
-
Mark
Mechanisms of HAMLET-induced cancer cell death
(
- Thesis › Doctoral thesis (compilation)